SEC reporting owner

Amado Rafael SEC insider disclosures

Explore Amado Rafael's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001662119
Issuers
4
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Adaptimmune Therapeutics PLC0001621227ADAPYesNo
Allogene Therapeutics, Inc.0001737287ALLOYesNo
Zai Lab Ltd0001704292ZLABYesNo
Poseida Therapeutics, Inc.0001661460PSTXNoYes

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2026-04-092026-04-06ZLABS2,739Not reported
2026-04-042026-04-02ZLABS9,910Not reported
2026-04-042026-03-04ZLABA14,905Not reported
2026-03-172026-03-13ZLABS2,957Not reported
2026-03-172026-03-04ZLABA33,783Not reported
2026-03-172026-03-04ZLABA103,950Not reported
2026-03-062026-03-03ZLABS10,000Not reported
2026-01-032025-12-31ZLABS10,787Not reported
2025-08-132025-08-08ZLABS3,000Not reported
2025-04-082025-04-04ZLABS3,029Not reported
2025-04-042025-04-02ZLABS7,541Not reported
2025-03-202025-03-17ZLABS3,000Not reported
2025-03-152025-03-12ZLABA21,294Not reported
2025-03-152025-03-12ZLABA65,523Not reported
2025-01-032024-12-31ZLABS7,583Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.